NexImmune, Inc. Human Resources Contracts & Agreements

14 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Consulting Agreement between NexImmune, Inc. and Jerome Zeldis, M.D., Ph.D., Effective April 1, 2023
Consulting Agreements
NexImmune, Inc.
Biotechnology
MD
2023
First Amendment to Employment Agreement between NexImmune, Inc. and Mathias Oelke
Employment Agreements
NexImmune, Inc.
Biotechnology
2022
Employment Agreement between NexImmune, Inc. and Mathias Oelke (Chief Science Officer)
Employment Agreements
NexImmune, Inc.
Biotechnology
MD
2022
Employment Agreement between NexImmune, Inc. and Kristi Jones (Chief Executive Officer and President)
Employment Agreements
NexImmune, Inc.
Biotechnology
MD
2022
Separation Agreement between NexImmune, Inc. and Scott Carmer (February 12, 2022)
Separation Agreements
NexImmune, Inc.
Biotechnology
MD
2022
NexImmune, Inc. Non-Employee Director Compensation Policy
Compensation Agreements
NexImmune, Inc.
Biotechnology
2021
NexImmune, Inc. Non-Employee Director Compensation Policy
Compensation Agreements
NexImmune, Inc.
Biotechnology
2021
Employment Agreement between NexImmune, Inc. and Robert Knight, M.D.
Employment Agreements
NexImmune, Inc.
Biotechnology
MD
2021
Employment Agreement between NexImmune, Inc. and Kristi Jones (Chief Business Officer)
Employment Agreements
NexImmune, Inc.
Biotechnology
MD
2021
Employment Agreement between NexImmune, Inc. and Jerome Zeldis, M.D., Ph.D.
Employment Agreements
NexImmune, Inc.
Biotechnology
MD
2021
Employment Agreement between NexImmune, Inc. and John Trainer (Chief Financial Officer)
Employment Agreements
NexImmune, Inc.
Biotechnology
MD
2021
Employment Agreement between NexImmune, Inc. and Scott Carmer (Chief Executive Officer)
Employment Agreements
NexImmune, Inc.
Biotechnology
MD
2021
NexImmune, Inc. 2021 Equity Incentive Plan
Bonus & Incentive Agreements
NexImmune, Inc.
Biotechnology
DE
2021
NexImmune, Inc. 2018 Equity Incentive Plan
Bonus & Incentive Agreements
NexImmune, Inc.
Biotechnology
DE
2021